RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cerevel Therapeutics Holdings Stock

Cerevel Therapeutics Holdings P/E 2024

Cerevel Therapeutics Holdings P/E

-14.09

Ticker

CERE

ISIN

US15678U1280

WKN

A2QF3L

As of Aug 25, 2024, Cerevel Therapeutics Holdings's P/E ratio was -14.09, a 15.59% change from the -12.19 P/E ratio recorded in the previous year.

The Cerevel Therapeutics Holdings P/E history

Cerevel Therapeutics Holdings Aktienanalyse

What does Cerevel Therapeutics Holdings do?

Cerevel Therapeutics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Cerevel Therapeutics Holdings's P/E Ratio

The Price to Earnings (P/E) Ratio of Cerevel Therapeutics Holdings is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Cerevel Therapeutics Holdings's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Cerevel Therapeutics Holdings is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Cerevel Therapeutics Holdings’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Cerevel Therapeutics Holdings stock

What is the price-to-earnings ratio of Cerevel Therapeutics Holdings?

The price-earnings ratio of Cerevel Therapeutics Holdings is currently -14.09.

How has the price-earnings ratio of Cerevel Therapeutics Holdings changed compared to last year?

The price-to-earnings ratio of Cerevel Therapeutics Holdings has increased by 15.59% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Cerevel Therapeutics Holdings high compared to other companies?

Yes, the price-to-earnings ratio of Cerevel Therapeutics Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of Cerevel Therapeutics Holdings affect the company?

An increase in the price-earnings ratio of Cerevel Therapeutics Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Cerevel Therapeutics Holdings affect the company?

A decrease in the price-earnings ratio of Cerevel Therapeutics Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Cerevel Therapeutics Holdings?

Some factors that influence the price-earnings ratio of Cerevel Therapeutics Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Cerevel Therapeutics Holdings pay?

Over the past 12 months, Cerevel Therapeutics Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerevel Therapeutics Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Cerevel Therapeutics Holdings?

The current dividend yield of Cerevel Therapeutics Holdings is .

When does Cerevel Therapeutics Holdings pay dividends?

Cerevel Therapeutics Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cerevel Therapeutics Holdings?

Cerevel Therapeutics Holdings paid dividends every year for the past 0 years.

What is the dividend of Cerevel Therapeutics Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cerevel Therapeutics Holdings located?

Cerevel Therapeutics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cerevel Therapeutics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cerevel Therapeutics Holdings from 8/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.

When did Cerevel Therapeutics Holdings pay the last dividend?

The last dividend was paid out on 8/25/2024.

What was the dividend of Cerevel Therapeutics Holdings in the year 2023?

In the year 2023, Cerevel Therapeutics Holdings distributed 0 USD as dividends.

In which currency does Cerevel Therapeutics Holdings pay out the dividend?

The dividends of Cerevel Therapeutics Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cerevel Therapeutics Holdings

Our stock analysis for Cerevel Therapeutics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerevel Therapeutics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.